LEO Pharma has been actively engaging with potential investors in recent months as it moves forward with plans for a possible stock market listing. Bloomberg posted on X, highlighting the company's strategic efforts to attract investment interest. The pharmaceutical firm is reportedly in the advanced stages of preparing for an initial public offering, aiming to strengthen its financial position and expand its market presence. This development comes amid a broader trend of healthcare companies seeking public listings to capitalize on market opportunities and drive growth. LEO Pharma's leadership is focused on ensuring a successful transition to the public market, leveraging investor relations to support its long-term objectives.